Your browser doesn't support javascript.
loading
Neuronal Rubicon Represses Extracellular APP/Amyloid ß Deposition in Alzheimer's Disease.
Espinoza, Sandra; Grunenwald, Felipe; Gomez, Wileidy; García, Felipe; Abarzúa-Catalan, Lorena; Oyarce-Pezoa, Sebastián; Hernandez, Maria Fernanda; Cortés, Bastián I; Uhrig, Markus; Ponce, Daniela P; Durán-Aniotz, Claudia; Hetz, Claudio; SanMartín, Carol D; Cornejo, Victor H; Ezquer, Fernando; Parra, Valentina; Behrens, Maria Isabel; Manque, Patricio A; Rojas-Rivera, Diego; Vidal, René L; Woehlbier, Ute; Nassif, Melissa.
Afiliación
  • Espinoza S; Laboratory of Neuroprotection and Autophagy, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Grunenwald F; Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Gomez W; Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • García F; Laboratory of Neuroprotection and Autophagy, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Abarzúa-Catalan L; Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Oyarce-Pezoa S; Laboratory of Neuroprotection and Autophagy, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Hernandez MF; Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Cortés BI; Laboratory of Neuroprotection and Autophagy, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Uhrig M; Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Ponce DP; Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Durán-Aniotz C; Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago 8580745, Chile.
  • Hetz C; Center for Regenerative Medicine, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago 7550000, Chile.
  • SanMartín CD; Centro de Investigación Clínica Avanzada, Universidad de Chile, Santiago 8380456, Chile.
  • Cornejo VH; Center for Social and Cognitive Neuroscience, School of Psychology, Universidad Adolfo Ibañez, Santiago 7550313, Chile.
  • Ezquer F; Center for Geroscience, Brain Health, and Metabolism, Santiago 8380453, Chile.
  • Parra V; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago 8380453, Chile.
  • Behrens MI; Buck Institute for Research on Aging, Novato, CA 94945, USA.
  • Manque PA; Centro de Investigación Clínica Avanzada, Universidad de Chile, Santiago 8380456, Chile.
  • Rojas-Rivera D; Departamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
  • Vidal RL; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago 8380453, Chile.
  • Woehlbier U; Center for Regenerative Medicine, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago 7550000, Chile.
  • Nassif M; Autophagy Research Center, Universidad de Chile, Santiago 8380456, Chile.
Cells ; 11(12)2022 06 07.
Article en En | MEDLINE | ID: mdl-35740989
Alzheimer's disease (AD) is the most prevalent age-associated neurodegenerative disease. A decrease in autophagy during aging contributes to brain disorders by accumulating potentially toxic substrates in neurons. Rubicon is a well-established inhibitor of autophagy in all cells. However, Rubicon participates in different pathways depending on cell type, and little information is currently available on neuronal Rubicon's role in the AD context. Here, we investigated the cell-specific expression of Rubicon in postmortem brain samples from AD patients and 5xFAD mice and its impact on amyloid ß burden in vivo and neuroblastoma cells. Further, we assessed Rubicon levels in human-induced pluripotent stem cells (hiPSCs), derived from early-to-moderate AD and in postmortem samples from severe AD patients. We found increased Rubicon levels in AD-hiPSCs and postmortem samples and a notable Rubicon localization in neurons. In AD transgenic mice lacking Rubicon, we observed intensified amyloid ß burden in the hippocampus and decreased Pacer and p62 levels. In APP-expressing neuroblastoma cells, increased APP/amyloid ß secretion in the medium was found when Rubicon was absent, which was not observed in cells depleted of Atg5, essential for autophagy, or Rab27a, required for exosome secretion. Our results propose an uncharacterized role of Rubicon on APP/amyloid ß homeostasis, in which neuronal Rubicon is a repressor of APP/amyloid ß secretion, defining a new way to target AD and other similar diseases therapeutically.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Enfermedad de Alzheimer / Proteínas Relacionadas con la Autofagia / Neuroblastoma Límite: Animals / Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Chile Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Neurodegenerativas / Enfermedad de Alzheimer / Proteínas Relacionadas con la Autofagia / Neuroblastoma Límite: Animals / Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Chile Pais de publicación: Suiza